dalteparin has been researched along with Carcinoma, Bronchial in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Züger, M | 1 |
| Demarmels Biasiutti, F | 1 |
| Wuillemin, WA | 1 |
| Furlan, M | 1 |
| Lämmle, B | 1 |
1 other study available for dalteparin and Carcinoma, Bronchial
| Article | Year |
|---|---|
Subcutaneous low-molecular-weight heparin for treatment of Trousseau's syndrome.
Topics: Aged; Anticoagulants; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Humans; Injections, S | 1997 |